Nuo Therapeutics, Inc.

符号: AURX

PNK

0.8

USD

今天的市场价格

-10.7721
市盈率
-0.1077
PEG比率
35.39M
MRK市值
0.00%
DIV收益率

Nuo Therapeutics, Inc. (AURX) 财务报表

Q: 什么是 Nuo Therapeutics, Inc. (AURX) 总资产是多少？

Nuo Therapeutics, Inc. (AURX) 总资产为 .

Download

年度季度

线性对数

在图表中，您可以看到的动态默认数字 Nuo Therapeutics, Inc. (AURX). 的默认数据。公司收入显示 NaN M 的平均值，即 NaN % 增长率。整个期间的平均毛利润为 NaN M，即 NaN %. 平均毛利率为 NaN %. 公司去年的净收入增长率为 NaN %，等于 NaN % % 整个公司历史的平均增长率.,

年度季度

10Y 20Y 30Y 40Y

资产负债表

深入分析 Nuo Therapeutics, Inc. 的财务轨迹，我们可以看到其平均资产增长率。有趣的是，这一增长率为，反映了公司的高点和低点。与季度相比，这一数字调整为. 回顾过去一年，总资产变化为 NaN. 股东权益总额所体现的股东价值是以报告货币计算的 NaN. 这方面的年同比变化率为 NaN%.

common:word.in-mln USD Growth	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000
balance-sheet.row.cash-and-short-term-investments	0.9	2.1	0.1	0.2	0.2	0.6	0.7	2.7	1	15.9	3.3	2.7	2.3	0.7	2.2	4	5.1	4.7	3.1	3.3	0.8	0.9	0.2	2.1	0.1
balance-sheet.row.short-term-investments	0	0	0	0	0.2	0	0	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.net-receivables	0.3	0.1	0	0	0	0	0.1	0.7	1	1.9	3.9	1.7	1.5	1.2	0.2	0.5	0.7	1	0.4	0.3	0.2	0.2	0	0.2	0
balance-sheet.row.inventory	0.2	0.2	0	0	0	0	0	0.1	0.3	0.6	1.1	1.2	0.5	0.6	166731	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-current-assets	0.2	0.2	0	0	0	0.2	0.3	0.3	0.8	2.3	0	0.1	0.8	1	0.2	0	0.1	0	0	0.3	0.2	0.3	0.3	0.1	0
balance-sheet.row.total-current-assets	1.6	2.6	0.1	0.2	0.2	0.9	1.2	3.8	3	21.9	10	6.4	5.2	3.5	2.5	4.7	6.1	5.8	3.8	3.9	1.2	1.4	0.5	2.5	0.2
balance-sheet.row.property-plant-equipment-net	0.3	0.4	0	0	0	0.1	0.2	0.5	1.1	0.9	0.9	2.4	1	1.3	0.1	0.1	0	0	0.1	0.2	0.2	0.3	0	0.5	0.1
balance-sheet.row.goodwill	0	0	0	0	0	0	0	2.1	0	1.1	1.1	1.1	0.7	0.7	0	0	2	2	2	0	0	0	0	0	0
balance-sheet.row.intangible-assets	0	0	0	0	0	0	0	7.8	2.5	28.7	33.8	34.1	2.9	3.2	0	0	1.7	1.8	2	4.1	4.2	4.4	0.6	0	0
balance-sheet.row.goodwill-and-intangible-assets	0	0	0	0	0	0	0	9.9	2.5	29.9	34.9	35.3	3.6	3.9	0	0	3.7	3.8	4	4.1	4.2	4.4	0.6	0	0
balance-sheet.row.long-term-investments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.tax-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-non-current-assets	0	0	0	0	0	0	0	0.3	0.4	3.5	0.5	0.2	0.3	0.2	0	0	0.2	0.6	0	0	0	0	0.1	0.9	0
balance-sheet.row.total-non-current-assets	0.3	0.4	0	0	0	0.1	0.2	10.7	4	34.3	36.3	37.9	4.9	5.4	0.1	0.1	3.9	4.4	4.1	4.3	4.5	4.7	0.7	1.4	0.1
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	1.9	3	0.1	0.2	0.2	1	1.4	14.5	7.1	56.2	46.3	44.3	10.1	8.9	2.6	4.8	10	10.2	7.9	8.2	5.7	6.2	1.2	3.9	0.3
balance-sheet.row.account-payables	0.4	0.4	0.5	0.5	0.5	0.4	0.4	0.4	1.1	1.9	3.4	1.4	1.2	3.6	1	1.3	0.1	1.2	1.1	1	0.6	0.7	0.1	0.8	0.1
balance-sheet.row.short-term-debt	0.1	0.1	0	0	0.7	0.3	0	-0.1	35	2.5	1.8	0	0	1.5	0	0	0.8	0	0	0	0	0	0.2	0	0.2
balance-sheet.row.tax-payables	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.long-term-debt-total	0.2	0.3	0	0	0	0	0	0	0	0.3	3.8	2.1	2.1	2	0	0	0	0	0	0	0	0	0	0	0
Deferred Revenue Non Current	0	0	0	0	0	0	0	0	0.6	1	1.4	-0.7	0	0	0	0	197344	191475	263745	0	0	0	0.6	0	0.1
balance-sheet.row.deferred-tax-liabilities-non-current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	0.3	0.1	0.1	0.1	0.1	0.3	0.5	1	5	3.7	2.9	1.4	1.3	0.1	0	0	0	0	0	0.2	0.1	0	0.1	-0.1	0
balance-sheet.row.total-non-current-liabilities	0.2	0.3	0	0	0	0.7	0	0.2	1.4	31.8	9.4	3.5	3.7	3.8	1	0.1	0.2	0.4	0.3	0.4	0.4	0.6	10	1.8	1.7
balance-sheet.row.other-liabilities	0	0	0	0	0	-0.7	0	0	0	0	0	0	0	0	-1	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	0.2	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	0.8	0.9	0.7	0.7	0.7	1.1	0.9	1.6	43.6	40.3	19.9	6.3	6.8	9	1	1.7	1.4	1.7	1.5	1.7	1.3	1.5	10.8	2.9	2.1
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	0	0	0	0	0	0	0	0	0	0.9	0.4	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.retained-earnings	-29.9	-26.8	-23.5	-23.5	-23.5	-22.2	-20.7	-5.2	-162.9	-110.1	-91.2	-71	-51.2	-47.7	-42.5	-39.1	-31.4	-26.6	-24.3	-17.7	-6.5	-2.1	-60.8	-39.6	-6.2
balance-sheet.row.accumulated-other-comprehensive-income-loss	0	0	0	0	0	0	0	-0.1	0	0	0	0	0	0	0	0	0	-0.6	-0.2	-1.4	-1.4	-0.2	0	0	0
balance-sheet.row.other-total-stockholders-equity	31	29	23	23	23	22.1	21.2	18.2	126.3	125.2	117.1	108.5	54.5	47.6	44.1	42.2	40	35.8	31	25.7	12.4	6.9	51.3	40.6	4.4
balance-sheet.row.total-stockholders-equity	1	2.2	-0.5	-0.5	-0.5	-0.1	0.5	12.9	-36.6	16	26.3	38	3.3	-0.1	1.5	3.1	8.6	8.5	6.4	6.5	4.5	4.7	-9.6	1	-1.8
balance-sheet.row.total-liabilities-and-stockholders-equity	1.9	3	0.1	0.2	0.2	1	1.4	14.5	7.1	56.2	46.3	44.3	10.1	8.9	2.6	4.8	10	10.2	7.9	8.2	5.7	6.2	1.2	3.9	0.3
balance-sheet.row.minority-interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-equity	1	2.2	-0.5	-0.5	-0.5	-0.1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.total-liabilities-and-total-equity	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	0	0	0	0	0.2	0	0	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-debt	0.3	0.3	0	0	0.7	0.3	0	0	35	0.3	5.6	2.1	2.1	3.5	0	0	0	0	0	0	0	0	0.2	0	0.2
balance-sheet.row.net-debt	-0.7	-1.7	-0.1	-0.2	0.5	-0.3	-0.7	-2.7	34.1	-15.6	2.3	-0.5	-0.1	2.9	-2.1	-4	-5.1	-4.7	-3.1	-3.3	-0.8	-0.9	0	-2.1	0.1

现金流量表

在 Nuo Therapeutics, Inc. 的财务状况中，自由现金流在过去一段时间内发生了显著变化，呈现出 NaN 的转变。该公司最近通过发行 NaN 扩大了股本，与上一年相比出现了NaN 的差异. 公司的投资活动产生了现金使用净额，按报告货币计算达到NaN. 与上一年相比， NaN 发生了变化. 在同一时期，公司记录了 NaN, NaN 和 NaN，这对于了解公司的投资和还款策略具有重要意义. 公司的融资活动导致使用的现金净额为NaN，同比差异为NaN. 此外，公司还将NaN 用于向股东分红。与此同时，该公司还采取了其他财务措施，即 NaN，这也对其在此期间的现金流产生了重大影响. 这些组成部分合在一起，全面反映了公司的财务状况和现金流管理的战略方针。

common:word.in-mln USD Growth	2022	2020	2018	2016	2014	2012	2010	2006	2004	2002	2000
cash-flows.row.net-income	-3.2	-3.2	0	0	0	-1.5	-15	-52.8	-18.9	-20.2	-19.8	-3.5	-6.8	-3.4	-7.7	-5	-2.3	-6.5	-8.1	-4.1	-2	-21.2	-33.3	-6.2
cash-flows.row.depreciation-and-amortization	0.1	0.1	0	0	0.1	0.1	1.1	0.7	0.6	1.1	1.2	0.6	0.4	0	0.2	0.2	0.2	2.2	3.3	1.2	0.1	0.5	0.1	0
cash-flows.row.deferred-income-tax	0	0	0	0	-0.4	-0.2	0	-0.1	0	0	0	0	0	-0.4	3.5	-1014966	-129794	-1526088	0	0	0	0	0	0
cash-flows.row.stock-based-compensation	0	0	13936	0.3	0.1	0	0.1	0.8	1.3	0.7	2	0.3	0.4	0.4	0.7	1014966	129794	1526088	0	0	0	0	0	0
cash-flows.row.change-in-working-capital	-0.3	-0.5	0	0	0	0.7	-0.3	0.2	0.8	5.2	-1.5	-1.3	1.6	-0.3	0.8	0.4	-0.8	-0.1	0.1	0.1	-0.6	0.5	0.4	0.1
cash-flows.row.account-receivables	-0.3	-0.1	0	0	0	0.3	277.1	695612	2005581	-2268104	-260510	-0.9	-1	0.3	0.2	0	0	0	0	0	0	0	0	0
cash-flows.row.inventory	0	-0.2	0	0	0	0	0	0.3	0.5	0.1	-0.6	0.1	0.5	287430.7	-377027.4	0	0	0	0	0	0	0	0	0
cash-flows.row.account-payables	0	0	0	0	0	0.1	0	-0.8	-1.5	5206301	-83767	-1055983	2356062	-287431	377028	-190818	98217	94678	0	0	0	0	0	0
cash-flows.row.other-working-capital	0	-0.2	0	0	0	0.4	-277.4	-695611.2	-2005579.2	-2938191.9	344276.1	1055982.5	-2356059.9	-0.3	-0.1	190818.4	-98217.8	-94678.1	0.1	0.1	-0.6	0.5	0.4	0
cash-flows.row.other-non-cash-items	0.2	-0.1	-13936	-0.3	-0.1	0	9.2	36.7	-1.2	1.9	6.7	-0.3	0.8	0.4	0	2.3	1.2	0.2	0	0.1	0.5	17.4	28.3	5.4
cash-flows.row.net-cash-provided-by-operating-activities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	0	-0.1	0	0	0	0	0	-0.7	-0.5	-0.8	-2.1	-0.1	-0.8	0	-0.1	0	0	0	-0.1	0	-0.3	0	-0.6	0
cash-flows.row.acquisitions-net	0	0	0	0	0	0	0	0	0	0	0	0	-2	0	0	0	0	0	0	0	0	-2.4	0	0
cash-flows.row.purchases-of-investments	0	0	0	0	0	0	0	0	0	0	0	0	0	-0.1	0	0	0	0	0	0	0	0	0	0
cash-flows.row.sales-maturities-of-investments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-investing-activites	0	0	0	0	0	0	0.1	0.1	0.1	2.1	0.5	0.1	0.1	0	0	0	0	0.1	0	0	0	0.2	-0.8	0.4
cash-flows.row.net-cash-used-for-investing-activites	0	-0.1	0	0	0	0	0.1	-0.6	-0.3	1.4	-1.6	0	-2.7	-0.1	-0.1	0	0	0.1	-0.1	0	-0.3	-2.3	-1.4	0.4
cash-flows.row.debt-repayment	0	0	0	0	0	0	0	0	-6.2	-1	-9.5	-2.6	-0.5	0	0	0	-11035	0	0	0	0	0	-0.2	-0.2
cash-flows.row.common-stock-issued	2	4.5	1.4	0.2	0	0.5	2.9	0	3.7	5.5	9.5	3.8	1.9	1.4	1.4	2.6	3.2	4	7.2	2.7	3.2	0	8	0.4
cash-flows.row.common-stock-repurchased	0	0	0	0	0	0	0	0	0	0	-0.2	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.dividends-paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-11035	-0.1	0	0	0	0	0	0
cash-flows.row.other-financing-activites	2	4.5	1373092	0.2	0.3	0.3	0	0	33	6.2	13.6	4.7	3.4	0	0	0	22070	0	0	-0.1	-0.1	3.2	0	0.2
cash-flows.row.net-cash-used-provided-by-financing-activities	2	4.5	1373092	0.2	0.3	0.8	2.9	0	30.4	10.7	13.4	5.8	4.8	1.4	1.4	2.6	3.2	3.9	7.2	2.6	3.1	3.2	7.8	0.4
cash-flows.row.effect-of-forex-changes-on-cash	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.net-change-in-cash	-1.2	0.7	0	0	0	-0.1	-1.9	-15	12.7	0.7	0.4	1.6	-1.5	-1.9	-1.1	0.5	1.5	-0.2	2.5	-0.1	0.9	-1.9	2	0.1
cash-flows.row.cash-at-end-of-period	0.9	2.1	0.1	0.2	0.2	0.6	0.7	0.9	15.9	3.3	2.6	2.2	0.6	2.1	4	5.1	4.7	3.1	3.3	0.8	1	0.2	2.1	0.1
cash-flows.row.cash-at-beginning-of-period	2.1	1.4	0.2	0.2	0.2	0.7	2.6	15.9	3.3	2.6	2.2	0.6	2.1	4	5.1	4.7	3.1	3.3	0.8	0.9	0.1	2.1	0.1	0
cash-flows.row.operating-cash-flow	-3.2	-3.7	0	0	0	-0.9	-4.9	-14.4	-17.4	-11.4	-11.4	-4.2	-3.5	-3.2	-2.5	-2.1	-1.7	-4.2	-4.7	-2.7	-1.9	-2.8	-4.4	-0.7
cash-flows.row.capital-expenditure	0	-0.1	0	0	0	0	0	-0.7	-0.5	-0.8	-2.1	-0.1	-0.8	0	-0.1	0	0	0	-0.1	0	-0.3	0	-0.6	0
cash-flows.row.free-cash-flow	-3.2	-3.8	0	0	0	-0.9	-4.9	-15.1	-17.9	-12.2	-13.5	-4.3	-4.3	-3.3	-2.6	-2.2	-1.7	-4.2	-4.8	-2.7	-2.2	-2.9	-5	-0.7

利润表行

Nuo Therapeutics, Inc. 的收入与上期相比变化了 NaN%。据报告, AURX 的毛利润为 NaN。该公司的营业费用为 NaN，与上年相比变化了 NaN%. 折旧和摊销费用为 NaN，与上一会计期间相比变化了 NaN%. 营业费用报告为 NaN，显示NaN% 的同比变化。销售和营销费用为 NaN, 其中 NaN% 与上年相比发生了变化。基于近期数据的EBITDA为 NaN，同比增长NaN%. 营业收入为 NaN，与上年相比变化了NaN%. 净利润的变化率为 NaN%。去年的净收入为NaN.

common:word.in-mln USD Growth	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000
income-statement-row.row.total-revenue	0.6	0.1	0	0	0.1	1.4	0.7	2205	11.5	7.8	11.6	10.6	7.2	3.9	2.1	2.1	1.9	1.9	1.5	1.1	1.1	0.4	0	0.3	0
income-statement-row.row.cost-of-revenue	0.1	0	0	0	0.1	0.2	1.1	1613	8	6.8	8.5	3.9	2.7	1.6	0.5	0.6	0.9	1	0.9	0.7	0.8	0.1	0	0.1	0
income-statement-row.row.gross-profit	0.5	0.1	0	0	0	1.2	-0.4	592	3.5	1	3.1	6.6	4.5	2.3	1.6	1.5	1.1	0.9	0.6	0.4	0.3	0.3	0	0.3	0
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	0	0	0	0	0	0	0.6	0	0	0	0	-2	1473670	1930655	2187696	6018366	1028137	1528361	4706508	0	0	0.4	3.7	31.9	3.2
income-statement-row.row.operating-expenses	3.7	3.4	0.1	0.4	1	2.7	5.9	0	17.8	19.7	21.2	19.5	8	7.7	5.1	5.8	6.4	5.1	8.1	8.6	4.5	2.4	5.5	33.7	3.5
income-statement-row.row.cost-and-expenses	3.8	3.4	0.1	0.4	1.1	2.9	7	1613	25.8	26.5	29.7	23.5	10.8	9.3	5.5	6.4	7.3	6.1	9	9.3	5.2	2.4	5.5	33.8	3.5
income-statement-row.row.interest-income	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0.2	0.1	0.1	0	0	0	0.2	0
income-statement-row.row.interest-expense	0	0	-48390	0	0.2	0	0	0	3.8	3.4	1.7	1	1	-0.8	0	0.2	-0.3	-1.9	-6.5	0	0	0	5.6	0	-6.2
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	0	0.1	287189	0.3	-0.2	0	-8.7	0	-34.9	3.3	-0.5	-5.8	1.1	-0.6	0	-3.5	0	1.7	0.8	0	0	-0.3	11.1	-0.4	-2.7
income-statement-row.row.ebitda-ratio-caps	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	0	0	0	0	0	0	0.6	0	0	0	0	-2	1473670	1930655	2187696	6018366	1028137	1528361	4706508	0	0	0.4	3.7	31.9	3.2
income-statement-row.row.total-operating-expenses	0	0.1	287189	0.3	-0.2	0	-8.7	0	-34.9	3.3	-0.5	-5.8	1.1	-0.6	0	-3.5	0	1.7	0.8	0	0	-0.3	11.1	-0.4	-2.7
income-statement-row.row.interest-expense	0	0	-48390	0	0.2	0	0	0	3.8	3.4	1.7	1	1	-0.8	0	0.2	-0.3	-1.9	-6.5	0	0	0	5.6	0	-6.2
income-statement-row.row.depreciation-and-amortization	0.1	0.1	0.1	0.1	0	0.1	1.1	0	0.7	0.6	1.1	1.2	0.6	0.4	0	0.2	0.2	0.2	2.2	3.3	1.2	0.1	0.5	0.1	0
income-statement-row.row.ebitda-caps	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	-3.2	-3.3	-0.1	-0.4	-1	-1.5	-15.5	592	-41.3	-23.4	-18.1	-12.9	-3.5	-5.4	-3.4	-7.9	-5.4	-4.2	-7.4	-8.2	-4.1	-2	-5.4	-33.5	-6.2
income-statement-row.row.income-before-tax	-3.2	-3.2	-0.1	-0.1	-1.2	-1.5	-15	0	-52.9	-18.9	-20.2	-19.8	-3.5	-6.8	-3.4	-7.7	-5	-2.3	-6.5	-8.1	-4.1	-2	-21.2	-33.3	-6.2
income-statement-row.row.income-tax-expense	0	-0.1	287188.9	0	0.2	0	-0.6	0	-0.1	0	0	0	0	0	0	-0.2	-0.3	-1.9	6.5	8.1	4.1	2	21.2	33.3	6.2
income-statement-row.row.net-income	-3.2	-3	-0.1	-0.1	-1.4	-1.5	-15	0	-52.8	-18.9	-20.2	-19.8	-3.5	-6.8	-3.4	-7.7	-5	-2.3	-6.5	-8.1	-4.1	-2	-21.2	-33.3	-6.2